ULTRAGENYX PHARMACEUTICAL INC.
Revenue Breakdown
| Fiscal Year | Product Sales Net | Collaboration and License Revenue | Royalty Revenue |
|---|---|---|---|
| FY2019 | $45.8M | $47.4M | $10.5M |
| FY2020 | $111.3M | $136.8M | $22.9M |
| FY2021 | $188.7M | $122.9M | $39.8M |
| FY2022 | $248.3M | $43.8M | $71.2M |
| FY2023 | $355.6M | $28.0M | $50.7M |